Patent details

Basic Information

Publication number:

EP3055325

PCT Application Number:

EP2014071236

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147805121

PCT Publication Number:

WO2015052088

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL DERIVATIVE OF AN INSULIN ANALOGUE

French Title of Invention:

NOUVEAU DÉRIVÉ D'INSULINE

German Title of Invention:

NEUARTIGE INSULINDERIVATE

SPC Number:

Dates

Filing date:

03/10/2014

Grant date:

03/01/2018

EP Publication Date:

17/08/2016

PCT Publication Date:

16/04/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/01/2018

EP B1 Publication Date:

03/01/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/10/2018

Expiration date:

03/10/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/12/2017

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

MADSEN, Peter

Address:

Denmark (DK)

2

Name:

TAGMOSE, Tina Møller

Address:

Denmark (DK)

3

Name:

NAVER, Helle

Address:

Denmark (DK)

4

Name:

KJELDSEN, Thomas Børglum

Address:

Denmark (DK)

Priority

Priority Number:

13187626

Priority Date:

07/10/2013

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 38/28; C07K 14/62;

Publication

European Patent Bulletin

Issue number:

201801

Publication date:

03/01/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1